A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards, taking children out of school and keeping parents off work.

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews

The world’s first norovirus vaccine is set to be trialled by the NHS in a bid to ease the strain on already stretched hospitals.

A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is set to be trialled on 25,000 people. Norovirus, commonly referred to as the “winter vomiting bug”, affects people of all ages and has had significant societal and healthcare impacts.

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 hospital admissions in the UK every year

A new vaccine is to be trialled in the UK to deal with norovirus. Also known as the 'winter vomiting bug', norovirus is a highly transmissible stomach bug that causes vomiting and diarrhoea.

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards,

Britain could become the first country to offer norovirus jab after early trial results found it creates a “strong immune response”.